Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 2, 2014, Pages 392-398

  McBride, Andrew ^a,b   Allen, Pamela ^a   Woodward, Wendy ^a   Kim, Michelle ^a   Kuerer, Henry M ^a   Drinka, Eva Katherine ^a   Sahin, Aysegul ^a   Strom, Eric A ^a   Buzdar, Aman ^a   Valero, Vicente ^a   Hortobagyi, Gabriel N ^a   Hunt, Kelly K ^a   Buchholz, Thomas A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CHEMOTHERAPY; DISEASES; PATIENT MONITORING; REGRESSION ANALYSIS;

ADJUVANT CHEMOTHERAPY; AROMATASE INHIBITORS; COX REGRESSION ANALYSIS; LOCOREGIONAL RECURRENCE; METHODS AND MATERIALS; POSITIVE LYMPH NODES; POSTMASTECTOMY RADIATION THERAPIES; SENTINEL LYMPH NODES;

PATIENT TREATMENT;

AROMATASE INHIBITOR;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; POSTMASTECTOMY RADIATION THERAPY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SYSTEMIC THERAPY;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK; SENTINEL LYMPH NODE BIOPSY; TIME FACTORS;

EID: 84899928365     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.02.013     Document Type: Article

References (24)

1. M. Overgaard, P.S. Hansen, and J. Overgaard et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy N Engl J Med 337 1997 949 955
2. M. Overgaard, M.B. Jensen, and J. Overgaard et al. Randomized trail evaluating postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen: Results from the DBCG 82c trial Lancet 353 1999 1641 1648
3. H.M. Nielsen, M. Overgaard, and C. Grau et al. Loco-regional recurrence after mastectomy in high-risk breast cancer - risk and prognosis: An analysis of patients from the DBCG 82 B&C randomization trials Radiother Oncol 79 2006 147 155
4. H.M. Nielsen, M. Overgaard, and C. Grau et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 B and C randomized studies J Clin Oncol 24 2006 2268 2275
5. J. Ragaz, S.M. Jackson, and N. Le et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 1997 956 962
6. J. Ragaz, I.A. Olivotto, and J.J. Spinelli et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
7. M. Clarke, R. Collins, and S. Darby et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106
8. J.R. Harris, P. Halpin-Murphy, and M. McNeese et al. Consensus statement on postmastectomy radiation therapy Int J Radiat Oncol Biol Phys 44 1999 989 990
9. A. Recht, S.B. Edge, and L.J. Solin et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 19 2001 1539 1569
10. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B&C randomized trials Radiother Oncol 82 2007 247 253
11. Darby S. 2006 Update from the Early Breast Cancer Trialists' Collaborative Group overview of radiation therapy for early breast cancer. Presented at the Annual Meeting of the American Society of Clinical Oncology, June 2007, Chicago, IL.
12. A. Katz, E.A. Strom, and T.A. Buchholz et al. Loco-regional recurrence patterns following mastectomy and doxorubicin-based chemotherapy. Implications for postoperative irradiation J Clin Oncol 18 2000 2817 2827
13. A. Recht, R. Gray, and N.E. Davidson et al. Locoregional failure ten years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group J Clin Oncol 17 1999 1689 1700
14. A. Taghian, J.H. Jeong, and E. Mamounas et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 22 2004 4247 4254
15. W.A. Woodward, E.A. Strom, and S.L. Tucker et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy radiation. Implications for patients with early stage disease and predictors for recurrence after radiation Int J Radiat Oncol Biol Phys 57 2003 336 344
16. A. Katz, E.A. Strom, and T.A. Buchholz et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy Int J Radiat Oncol Biol Phys 50 2001 735 742
17. R. Sharma, I. Bedrosian, and A. Lucci et al. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy Ann Surg Oncol 17 2010 2899 2908
18. S. Koscielny, and H.D. Thames Biased methods for estimating local and distant failure rates in breast carcinoma and a "commonsense" approach Cancer 92 2001 2220 2227
19. R.D. Tendulkar, S. Rehman, and M.E. Shukla et al. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy Int J Radiat Oncol Biol Phys 83 2012 e577 e581
20. T. Moo, R. McMillian, and M. Lee et al. Selection criteria for postmastectomy radiotherapy in T1-T2 tumors with 1 to 3 positive lymph nodes Ann Surg Oncol 20 2013 3169 3174
21. J.C. Cheng, C.M. Chen, and M.C. Liu et al. Locoregional failure of post-mastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy Int J Radiat Oncol Biol Phys 52 2002 980 988
22. P.S. Yang, C.M. Chen, and M.C. Liu et al. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 or T2 breast cancer and one to three positive nodes with estrogen receptor and positive lymphovascular invasion status Int J Radiat Oncol Biol Phys 77 2010 516 522
23. P.T. Truong, I.A. Olivotto, and H.A. Kader et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy Int J Radiat Oncol Biol Phys 61 2005 1337 1347
24. E.E. Harris, J. Freilich, and H.Y. Lin et al. The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy Int J Radiat Oncol Biol Phys 85 2013 609 614